Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials? [electronic resource]
- European heart journal 04 2017
- 1044-1047 p. digital
Publication Type: Journal Article; Comment
1522-9645
10.1093/eurheartj/ehx110 doi
Drug Therapy, Combination Drug-Eluting Stents Humans Platelet Aggregation Inhibitors Ticlopidine